Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMPD1 | P17405 | 5/20 | 0.41 |
| ▸ | ESR1 | P03372 | 2/20 | 0.41 |
| ▸ | THRA | P10827 | 2/20 | 0.39 |
| ▸ | THRB | P10828 | 2/20 | 0.39 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.38 |
| ▸ | PDE4B | Q07343 | 2/20 | 0.38 |
| ▸ | S1PR2 | O95136 | 1/20 | 0.36 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.36 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.36 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL862834 | 0.95 | SMPD1 (0.40) | SMPD1ESR1THRATHRBALOX5 | |
| SCHEMBL10153468 | 0.93 | SMPD1 (0.37) | SMPD1ESR1THRATHRBALOX5 | |
| SCHEMBL13030818 | 0.93 | HMGCR (0.47) | SMPD1ESR1THRATHRB | |
| SCHEMBL13759588 | 0.93 | HMGCR (0.47) | SMPD1ESR1THRATHRB | |
| SCHEMBL14570394 | 0.93 | HMGCR (0.47) | SMPD1ESR1THRATHRB | |
| SCHEMBL862517 | 0.92 | ESR1 (0.43) | ESR1THRATHRBS1PR2S1PR1 | |
| SCHEMBL12252238 | 0.92 | ESR1 (0.43) | ESR1THRATHRBS1PR2S1PR1 | |
| SCHEMBL862614 | 0.89 | ESR1 (0.42) | ESR1THRATHRBS1PR2S1PR1 | |
| SCHEMBL10153565 | 0.89 | SMPD1 (0.36) | SMPD1ESR1THRATHRBPDE4B | |
| SCHEMBL11983258 | 0.87 | SMPD1 (0.47) | SMPD1ESR1THRATHRBALOX5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8142908-B2 | Polymer light-emitting material comprising a conjugated polymer and compound exhibiting light emission from the triplet excited state and polymer light-emitting device using the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-03-27 | — | — | US | disclosed |
| US-8012603-B2 | Polyanilines; strong fluorescence and large charge transporting properties | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-09-06 | — | — | US | disclosed |
| US-20080138651-A1 | Polyanilines; strong fluorescence and large charge transporting properties | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2008-06-12 | — | — | US | disclosed |
| US-7208567-B2 | Polymer compound and polymer light emitting device using the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2007-04-24 | — | — | US | disclosed |
| US-20070051922-A1 | Polymer light-emitting material and polymer light-emitting device | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2007-03-08 | — | — | US | disclosed |
| US-20070040164-A1 | Polymer complex compound and polymer light emitting device using the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2007-02-22 | — | — | US | disclosed |
| US-7157154-B2 | Organoboron polymers; photoconductivity; inks; thin films; semiconductors; surface light sources; dot matrix displays | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2007-01-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080138651-A1 | Polyanilines; strong fluorescence and large charge transporting properties | BRS3, SLC43A1, MRPS23 | SMPD1 4418/4885ESR1 1141/4885THRA 2652/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.